Stock listing

NYSE:MRK Merck & Company, Inc. Stock

Home listing (NYSE) of Merck & Company, Inc.

Follow Merck & Company, Inc. into a list and get an email when it puts out news.

Share price · NYSE:MRK

$145.95 USD +0.76 (+0.5%)

Close on Oct 16, 2026

Merck & Company, Inc. logo
Ticker
NYSE:MRK
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
NYSE
Currency
USD

What changed lately

Calls

Upcoming

  • Merck & (NYSE:MRK) Q3 2026 Earnings Call

    Thu, Oct 29, 2026 · 9:00 AM ET

    Register

Replays

  • Merck & (NYSE:MRK) Q2 2026 Earnings Call

    Tue, Aug 04, 2026 · 9:00 AM ET

    Watch Transcript

  • Merck & (NYSE:MRK) Q1 2026 Earnings Call

    Thu, Apr 30, 2026 · 9:00 AM ET

    Watch Transcript

  • Merck & (NYSE:MRK) Q4 2025 Earnings Call

    Tue, Feb 03, 2026 · 9:00 AM ET

    Watch Transcript

Latest news

Inaugurates State-of-the-Art ADVANCE Bioanalytical Facility on West Point, Pennsylvania, Campus

Oct 14, 2026

Paul J. Diaz Elected to Merck & Co., Inc., Rahway, N.J., USA Board of Directors

Oct 13, 2026

Merck Showcases First-Time Pivotal Phase 3 Results From Oncology Pipeline and Continued Innovative Potential of Existing Portfolio at ESMO 2026

Oct 13, 2026

Merck Presents One-Year Results from the Pivotal Phase 2b/3 BRUNELLO Study Evaluating Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, in Adults with Diabetic Macular Edema at AAO 2026

Oct 10, 2026

Merck &: EMD Electronics Opens New R&D Facility in Wisconsin to Accelerate Advanced Semiconductor M

Oct 2, 2026

Merck to Hold Third-Quarter 2026 Sales and Earnings Conference Call Oct. 29

Oct 1, 2026

Merck's Tulisokibart Met Primary and Key Secondary Endpoints in Phase 2b Study in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)

Sep 30, 2026

CAPVAXIVE® Included in Ontario's Publicly Funded Adult Pneumococcal Immunization Program

Sep 28, 2026

Merck Enters into Exclusive Global License Agreement with SciBrunch Therapeutics for SPR2015, an Investigational Oral KRAS G12D (ON) Inhibitor

Sep 28, 2026

U.S. FDA Approves WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) for Certain Previously Treated Adult Patients With Advanced Renal Cell Carcinoma With a Clear Cell Component (ccRCC)

Sep 25, 2026

All Merck & Company, Inc. news

Decks

Merck & Company, Inc. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
178 in the last 12 months · 178 in all · newest Oct 14, 2026 · oldest 2025
Calls
31 calls with a replay · 31 with a transcript · latest Aug 4, 2026
Decks
94 decks · latest Aug 4, 2026

Where Merck & Company, Inc. is listed

ListingExchangeCountryCurrency
NYSE:MRK · Home listing · This pageNYSEUnited StatesUSD
gettex:6MKgettexGermanyEUR
BCBA:MRKBCBAArgentinaARS
Xetra:6MKXetraGermanyEUR
Tradegate:6MKTradegateGermanyEUR
BMV:MRKBMVMexicoMXN
BCBA:MRKDBCBAArgentinaUSD
B3:MRCK34B3BrazilBRL
Milan:1MRKXMilanItalyEUR
TSX:MRKTSXCanadaCAD
LS Exchange:A0YD8QLS ExchangeGermanyEUR
Cboe Canada:MRKCboe CanadaCanadaCAD
Frankfurt:6MKFrankfurtGermanyEUR
Lang & Schwarz:A0YD8QLang & SchwarzGermanyEUR
BCS:MRKCLBCSChileCLP
SIX Swiss:MRK.USDSIX SwissSwitzerlandUSD
LSE:0QAHLSEUnited KingdomUSD
BOATS:MRKBOATSUnited StatesUSD
BIVA:MRKBIVAMexicoMXN
BCS:MRKBCSChileUSD
SIX Swiss:MRKSIX SwissSwitzerlandCHF
EUROTLX:4MRKXEUROTLXItalyEUR
VIE:MRKViennaAustriaEUR
BCBA:MRK.BBCBAArgentinaARS
BCBA:MRKCBCBAArgentinaUSD
Hanover:6MKHanoverGermanyEUR
Stuttgart:6MKStuttgartGermanyEUR
Dusseldorf:6MKDusseldorfGermanyEUR
BSESOF:6MKBSESOFBulgariaEUR
BVL:MRKUSBVLPeruPEN
Hamburg:6MKHamburgGermanyEUR
Munich:6MKMunichGermanyEUR
BX Swiss:6MKBX SwissSwitzerlandCHF
Turquoise:MRKNTurquoiseUnited KingdomUSD
Aquis:6MKDAquisUnited KingdomEUR
Aquis:6MKDAquisUnited KingdomEUR
Frankfurt:6MK0FrankfurtGermanyEUR
BCBA:MRK.CIBCBAArgentinaARS

Log in to ask 6ix AI your own questions about Merck & Company, Inc.